Sublingual Versus Vaginal Misoprostol In Medical Treatment of Second Trimestric Missed Miscarriage

• Status: Not yet recruiting
• Trial end date: 2023-03-31
• Target enrollment: 0
• Participant gender: Female

Summary

The aim of this work is to compare the effectiveness of vaginal versus sub-lingual misoprostol for medical treatment of the second trimester missed miscarriage

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Aswan University Hospital
• Treatments: Misoprostol

Criteria

Inclusion Criteria:

• All women above 18 years of age

• between 13-26 weeks of gestation.

• Pregnancy is confirmed by a pregnancy test or ultrasound scan.

• missed abortion

• Normal general and gynecological examination.

Exclusion Criteria:

• Hemodynamically unstable.

• Suspected sepsis with temperature 38 °C.

• Concurrent medical illness e.g. hematological, cardiovascular, thromboembolism,

• respiratory illnesses, recent liver disease, or pruritus of pregnancy.

• Presence of intrauterine contraceptive device (IUCD).

• Suspect or proven ectopic pregnancy.

• -Failed medical or surgical evacuation before the presentation.

• Known allergy to misoprostol.